David Dodd/GeoVax GeoVax Labs is a clinical-stage biotechnology company developing novel therapies and vaccines for cancers and many of the world’s most threatening infectious diseases. The company’s lead program in oncology is a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, presently in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax’s [&#8230;]

SIMON SAYS, LET’S TALK BUSINESS:  Tim Yoder with Duratec Roofing Solutions and J.C. Laurent with Penon Partners

Al Simon of Sandler Training by Simon interviews local business owners and sales professionals about some of the sales challenges they face and things they can do to increase sales for their organizations.